Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. | Hum Psychopharmacol;25(2): 133-8, 2010 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment.

Maayan, Lawrence A; Vakhrusheva, Julia.

Affiliation

Maayan LA; Nathan S. Kline Institute for Psychiatric Research, NY 10962, USA. LMaayan@nki.rfmh.org

Hum Psychopharmacol ; 25(2): 133-8, 2010 Mar.

Article in En | MEDLINE | ID: mdl-20196182

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Weight Gain / Antidepressive Agents, Second-Generation / Risperidone / Leptin / Body Size Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Hum Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2010 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Weight Gain / Antidepressive Agents, Second-Generation / Risperidone / Leptin / Body Size Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Hum Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2010 Document type: Article Affiliation country: